Performing a gene and cell therapy trial for heart attack patients: an interview with Duncan Stewart
In this interview, Dr. Duncan Stewart from the Ontario Institute for Regenerative Medicine discusses his ongoing ENACT-AMI trial studying angiogenic cell therapy to promote repair after a massive heart attack using eNOS-enhanced EPCs.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>